echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > European Radiology: Anterior chamber fortification predicts optic nerve invasion in retinoblastoma!

    European Radiology: Anterior chamber fortification predicts optic nerve invasion in retinoblastoma!

    • Last Update: 2023-01-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In children with retinoblastoma (RB), optic nerve (ON) infiltration is a major risk factor
    for advanced disease.
    Orbital MRI
    is an important imaging modality
    to determine risk factors for advanced disease such as ON infiltration.

    The function of the orbital lymphatic system is consistent with that of the brain, maintaining retinal balance
    by mediating the removal of toxic metabolites around blood vessels from the retina to distal ON.
    While it is well known that the sugar water pathway within the orbit can be observed with GBCA-enhanced heavy T2-weighted (hT2) MRI, standard T1-weighted generally does not show the small amount of GBCA
    crossing the blood-eye barrier after intravenous injection.

    Recently, a study published in the journal European Radiology evaluated imaging markers of ON infiltration in a large cohort of a national RB center, providing an imaging reference for accurate preoperative risk stratification of RB patients
    .

    The study included 539 orbital MRIs performed with orbital coils, each child under general anaesthesia
    .
    Differences in AC-to-lens signal intensity ratios (ΔSIRs) were determined between plain sweep and GBCA-enhanced T1-weighted images and correlated with
    histopathologically present ON infiltrates.

    In a multivariate analysis adjusted for tumor size, the ∆SIR of RB eyes was an independent and significant predictor of ON infiltration (P < 0.
    05) and increased
    with increasing degree of infiltration.


    Figure Retinal
    blastoma with optic nerve invasion as an example
    of orbital MRI.
    Sagittal (A, F) and axial fat saturation (B, G) T1-weighted MRI after injection of gadolinium contrast agent (GBCA).

    Axial
    T2-weighted (C, H), axial primitive (D, I), and GBCA enhanced (E, J) T1-weighted MRI images
    .
    (A-E) A 36-month-old boy with right-sided retinoblastoma (RB) with optic nerve (ON) infiltration
    .
    While the anterior chamber (AC) of the right eye shows GBCA enhancement (short arrow of B+E), the optic nerve does not show GBCA enhancement (long arrow of B+E).

    Subsequent histological analysis shows ON infiltration before lamination
    .
    (F-J) A 40-month-old boy with right RB with
    ON infiltration
    .
    Both the right AC and the distal ON show significant GBCA enhancement (G, J, short and long arrows, respectively).

    This study reveals a correlation between anterior chamber GBCA enhancement and optic nerve invasion in retinoblastoma, which may be due to intraorbital lymphatic dysfunction, and may serve as an important indication
    of increased brain GBCA excretion in the diagnosis of neurological pathology.

    Original source:

    Katerina Deike-Hofmann,Paula von Lampe,Maija Eerikaeinen,et al.
    Anterior chamber enhancement predicts optic nerve infiltration in retinoblastoma.
    DOI:10.
    1007/s00330-022-08778-4

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.